Italian Retrospective and Prospective Observation of Antiretroviral Treatment in Patients Taking DarunavIr/cobicistAt Plus eMtricitabine and Tenofovir AlafeNamide fumaraTE - DIAMANTE
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2019
Price : $35 *
At a glance
- Drugs Cobicistat/darunavir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms DIAMANTE
- Sponsors Janssen-Cilag
- 25 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Jul 2019 Planned End Date changed from 30 Jun 2020 to 31 Jul 2020.
- 14 May 2019 Planned End Date changed from 31 Mar 2020 to 30 Jun 2020.